In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Sanofi

House Committees Want BARDA Coronavirus Vaccine, Treatment Contract Info

Request for documents and a briefing is part of efforts to ensure federal programs are ‘protected from price gouging.’

Coronavirus COVID-19 Vaccines

COVID And Beyond: China Urged To Address Chronic Disease, Improve Access

Facing the aftermath of coronavirus disruption and supply chain reorganization, executives of multinational drug firms in China say the government needs to do more to help address a flurry of issues laid bare by the public health crisis.

China Business Strategies

For COVID, Consensus On Value Of Platform Trials, But A Confusion Of Consortia

The coronavirus pandemic could be a turning point for master protocol and platform trial designs, but clear guidance and coordination are still needed.

Coronavirus COVID-19 Clinical Trials

Pfizer’s Hopes For Ibrance In Adjuvant Breast Cancer Fall With PALLAS

Ibrance (palbociclib) is unlikely to succeed in the adjuvant trial, the data safety monitoring board concluded. Pfizer has another adjuvant trial due later this year. 

Clinical Trials Research & Development
See All

Company Information

UsernamePublicRestriction

Register